Title(s): 11026. A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy
Investigator(s):
Esther Rehmus, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
